Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SHOGOODY. The owner is based in chongqing.
DaShiBa, JiangBei District
chongqing 400000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Chongqing Jingrongshui Environmental Protection Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. have?
Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. file in?
Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Chongqing Jingrongshui Environmental Protection Technology Co., Ltd.'s most well-known trademarks?
Chongqing Jingrongshui Environmental Protection Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as SHOGOODY. These are among 1 currently registered trademark in the portfolio.
What is Chongqing Jingrongshui Environmental Protection Technology Co., Ltd.'s trademark registration success rate?
Chongqing Jingrongshui Environmental Protection Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.